Christopher Graber

Amplifying Our Voices: Fostering Advocacy in Infectious Diseases Fellowship This white paper, devised from the Infectious Diseases Society of America's National Training Program Director annual meeting, outlines practical strategie

With UW’s Dr Paul Pottinger and others, new discussion re: fostering ID advocacy in ID fellowship.

They note:
Policies with a negative impact on ID clinical care, public health, & research underscore the importance of mobilizing the field of ID to advocacy

academic.oup.com/ofid/advance... #IDSky

5. The Learner (redux): the late career person who no longer has to play hard at the game and is at the meeting for the science and to have awesome dinners with friends.

Making it to this stage is the aspirational goal.

4. The Leader: the mid to late career person who mostly goes to meet with other key Leaders to plan grants, policies, and initiatives. Only catches a few educational sessions. Comes late and leaves early.

3. The Organizer: the midcareer person involved in planning sessions, moderating, leading symposia, getting people to meet who need to meet. Lucky to make it to half the educational stuff they aren’t involved in.

2. The Presenter: the trainee or early career person who has a poster or oral presentation, still learns and absorbs most of the meeting, but the presentation is the focus.

beginning to realize the stages of @idweek.bsky.social attendance according to career stage:

1. The Learner: the student/resident/fellow that goes to learn and absorb.

the day that AI can do schedule-making better than me is the day my work is done as a PD…it’s gonna be a while

Transplant Infectious Diseases Career Development Position 2026-2027 University of California, Los Angeles is hiring. Apply now!

Feeling inspired seeing so many enthusiastic trainees at #IDWeek2025! We have a 2026-27 opening for our 1-year Transplant ID Advanced Training Program at #UCLA, pls reach out with any questions #IDfellow #TxID @idweek.bsky.social #IDSky @ucla-id-fellowship.bsky.social recruit.apo.ucla.edu/JPF10380

Well done to all the teams! Time for everyone to start making plans for BugBowl 2026 in DC!

Get psyched! Come for the ATL-themed puns, stay for the knowledge!

DOT-ting i's and crossing t's: More evidence for using long-acting glycopeptides to finish therapy of complicated S. aureus bacteremia A JAMA study looked at dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. Read IDSA's Journal Club review.

On IDSA’s & HIVMA’s Science Speaks blog: Christopher J. Graber, MD, MPH, FIDSA, explores dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. https://bit.ly/4ncqnAt

Looking to do some stewardship and/or hospital epi? Join me, @wbranchelliman.bsky.social, and our crew at VA Greater Los Angeles!

best admin assistant (and pre-interview Zoom DJ) ever!

Colleagues- in case this was missed during summer vacation, please share. I just went to the Bowl again last week and saw Yo-Yo Ma and Angelique Kidjo. The Bowl is not the only reason to be in LA....but it is pretty spectacular. Also my ASP team is just the bee's knees.

Comparison of Patients With Coccidioidomycosis in Arizona Versus California: A Commercial Health Insurance Claims Analysis Abstract. Commercially insured patients with coccidioidomycosis in Arizona (n = 1640) were more likely to have symptoms indicating acute pulmonary disease

Calling it a showdown would be vastly overstating it. Fun article that notes differences in cocci presentations in CA vs AZ that we think are driven by inherent population and care pattern differences and not anything inherent to immitis vs posadasii

academic.oup.com/ofid/article...

the marker of a good journal club is that the fellows have already left for clinic and the attendings are still arguing

I demand a randomized controlled trial of hiring people who resign back to their prior jobs. The public deserves nothing less.

Broad-spectrum antibiotics for moderately immunocompromised patients with CAP: An overdone practice A study in CID examined broad-spectrum antibiotics in moderately immunocompromised patients with community-acquired pneumonia

Moderate immunocompromise (even if overly broadly defined) should not buy you vanc + antipseudomonal for CAP: my latest @idsainfo.bsky.social Journal Club review:

www.idsociety.org/science-spea...

my fellow just put up a slide in case conference with the “distracted boyfriend” meme for linezolid overtaking clindamycin as the “toxin” drug of choice and never have I been more proud as a program director

let’s goooooooooooooo

we’ve all been there, right?

most men aren’t complicated, it turns out (at least as it pertains to UTI)

you’re damn right I’m giving feedback on every internal medicine LKA question I miss as being a bad question

good reminder for all the new trainees: antibiotics don’t fix structural abnormalities

ID is about so much more than picking the correct antibiotics

Shorter may be better, but how (and how much better)? A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance.

On IDSA’s & HIVMA’s Science Speaks blog: A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA. buff.ly/CDwwOlf

Shorter may be better, but how (and how much better)? A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance.

IDSA Journal Club is back, baby! My latest on the perhaps questionable effect of shortening antimicrobial courses of therapy on the gut microbiome:

www.idsociety.org/science-spea...

you and I prepare for talks differently…this morning on my run I decided that my fellowship graduation speech is going to involve a story about how Michael Stipe came up with lyrics for an R.E.M. deep album cut from 1991 and a YouTube video involving a honey badger and I’m gonna wing it from there

Deadline approaching! Submit your team of ID trivia powerhouses to compete in IDBugBowl, a Jeopardy-style competition held at #IDWeek2025: buff.ly/JUFUcel

IDWeek will pay FULL conference registration for student, resident & fellow team participants.

Apply by 5/16.